Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial investigating mycophenolate mofetil, tacrolimus, daclizumab, and donor peripheral stem cell transplantation for hemat…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating peripheral stem cell transplantation with combination chemotherapy and monoclonal antibody therapy …
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 4]
Phase 4 clinical trial update on bone marrow transplantation for hematologic cancers, including conditions such as anemia and graft-versus-h…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating bone marrow transplantation from fully matched relatives as donors for hematologic malignancies has completed; resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma [Phase 2]
Phase 2 clinical trial evaluating doxorubicin hydrochloride liposome with rituximab in combination chemotherapy for newly diagnosed Burkitt'…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on donor umbilical cord blood transplant for hematologic cancers; status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma [NA]
Clinical trial update on promoting resiliency among lymphoma survivors; status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating total-body irradiation with fludarabine and peripheral stem cell transplantation in patients with hematologic cance…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) [Phase 2]
Phase 2 trial comparing lenalidomide to investigator's choice in relapsed or refractory mantle cell lymphoma has completed; results posted i…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias [Phase 1]
Phase I study evaluating NK cell infusions after allogeneic stem cell transplantation in pediatric leukemia and lymphoma patients has comple…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating bortezomib with chemotherapy in lymphoid malignancies undergoing stem cell transplantation; results posted…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects [Phase 2]
A Phase 2 clinical trial update for XLCART001 in relapsed/refractory/high-risk B-cell malignancies is underway, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma [Phase 2]
Phase 2 trial evaluating sirolimus and methotrexate in relapsed/refractory lymphoblastic leukemia and lymphoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Molecular and Whole-body MR Imaging in Lymphomas [NA]
Completed clinical trial investigating molecular and whole-body MRI imaging methods in lymphoma patients; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients [Phase 2]
Phase 2 study of PQR309 in relapsed or refractory lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies [Phase 1, Phase 2]
Early-phase clinical trial update on CD20-targeted CAR-T therapy for B cell malignancies (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CAR T cells targeting CD19 for malignant B-cell leukemia and lymphoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies [Phase 1, Phase 2]
Clinical trial update on CD22-targeted CAR-T for B cell malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies [Phase 1, Phase 2]
A clinical trial update regarding CD30-targeted CAR-T therapy in lymphocyte malignancies spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial update evaluating the food effect of alisertib (MLN8237) in participants with advanced solid tumors or lymphomas; study comple…
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma [Phase 3]
A Phase 3 randomized trial comparing chlorambucil alone, chlorambucil with rituximab, and rituximab alone in MALT lymphoma has been complete…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT) [Phase 2]
Phase 2 trial update of Brentuximab Vedotin in high-risk CD30+ lymphoma after allogeneic stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of rituximab, bendamustine, and lenalidomide in aggressive B-cell lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma [Phase 3]
Phase 3 trial update evaluating a monoclonal antibody therapy for lymphoma (follicular or mantle cell) has completed.